Salivary gland tumor staging: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 94: Line 94:
|}
|}


{| style="border: 0px; font-size: 90%; margin: 3px; width: 800px" align=center
|valign=top|
|+
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|N classification}}
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|Nodal Mass}}
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:M0
| style="padding: 5px 5px; background: #F5F5F5;" |No distant metastasis
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |
:M1
| style="padding: 5px 5px; background: #F5F5F5;" |Distant metastasis
|-
|}





Revision as of 20:52, 29 October 2015

Salivary gland tumor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Salivary gland tumor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Fine-needle Aspiration Biopsy (FNAB)

Head X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Salivary gland tumor staging On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Salivary gland tumor staging

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Salivary gland tumor staging

CDC on Salivary gland tumor staging

Salivary gland tumor staging in the news

Blogs on Salivary gland tumor staging

Directions to Hospitals Treating Salivary gland tumor

Risk calculators and risk factors for Salivary gland tumor staging

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.



Stage Tumor location
TX
Primary tumor cannot be assessed
T0
No evidence of a primary tumor
T1
Tumor ≤2 cm in greatest dimension without extraparenchymal extension.
T2
Tumor >2 cm but ≤4 cm in greatest dimension without extraparenchymal extension
T3
Tumor >4 cm and/or tumor having extraparenchymal extension.
T4a
  • Moderately advanced disease.
  • Tumor invades skin, mandible, ear canal, and/or facial nerve.
T4b
  • Very advanced disease.
  • Tumor invades skull base and/or pterygoid plates and/or encases carotid artery.


N classification Nodal Mass
NX
Regional lymph nodes cannot be assessed
N0
No regional lymph node metastasis.
N1
Metastasis in a single ipsilateral lymph node, ≤3 cm in greatest dimension.
N2
  • Metastasis in a single ipsilateral lymph node, >3 cm but ≤6 cm in greatest dimension.
  • Metastases in multiple ipsilateral lymph nodes, ≤6 cm in greatest dimension.
  • Metastases in bilateral or contralateral lymph nodes, ≤6 cm in greatest dimension.
N2a
  • Metastasis in a single ipsilateral lymph node, >3 cm but ≤6 cm in greatest dimension
N2b
  • Metastases in multiple ipsilateral lymph nodes, ≤6 cm in greatest dimension.
N2c
  • Metastases in bilateral or contralateral lymph nodes, ≤6 cm in greatest dimension.
N3
  • Metastases in bilateral or contralateral lymph nodes, ≤6 cm in greatest dimension.
N classification Nodal Mass
M0
No distant metastasis
M1
Distant metastasis


References

Template:WH Template:WS